Approval · Notice of Compliance 34225 · 2024
LOLO: Notice of Compliance 34225
Issued October 17, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34225
- Date
- October 17, 2024
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOLO | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 10 MCG per TAB
- NORETHINDRONE ACETATE 1 MG per TAB